Showing results (681-690 of 694) with videos related to

Sort By:
Pageof 70
Environment International|December 26, 2018
WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of exposure to occupational ergonomic risk factors and of the effect of exposure to occupational ergonomic risk factors on osteoarthritis of hip or knee and selected other musculoskeletal diseasesCarel T J Hulshof, Claudio Colosio, Joost G Daams, et al.
Trials|March 17, 2021
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trialKarin Welén, Anna K Överby, Clas Ahlm, et al.
The Journal of Investigative Dermatology|January 16, 2007
CDKN2A germline mutations in individuals with cutaneous malignant melanomaIrene Orlow, Colin B Begg, Javier Cotignola, et al.
European Urology|January 4, 2022
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro DataKarin Welén, Ebba Rosendal, Magnus Gisslén, et al.
Chemmedchem|December 4, 2014
Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorptionAbbas M Walji, Rosa I Sanchez, Sophie-Dorothee Clas, et al.
JCI Insight|October 19, 2021
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccinationAlberto Cagigi, Meng Yu, Björn Österberg, et al.
Science Translational Medicine|March 16, 2022
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantavirusesEva Mittler, Anna Z Wec, Janne Tynell, et al.
Science Translational Medicine|June 14, 2023
Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibodyEva Mittler, Alexandra Serris, Emma S Esterman, et al.
Journal of Medicinal Chemistry|September 24, 2015
Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer InhibitorsIzzat T Raheem, Abbas M Walji, Daniel Klein, et al.
Neurology|February 10, 2025
Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi StudySeverin Schramm, Corinna Börner-Schröder, Miriam Reichert, et al.
Pageof 70